0001013762-11-002295.txt : 20110819 0001013762-11-002295.hdr.sgml : 20110819 20110819101135 ACCESSION NUMBER: 0001013762-11-002295 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110815 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20110819 DATE AS OF CHANGE: 20110819 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medefile International, Inc. CENTRAL INDEX KEY: 0000842013 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 850368333 STATE OF INCORPORATION: NV FISCAL YEAR END: 0121 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 033-25126-D FILM NUMBER: 111046260 BUSINESS ADDRESS: STREET 1: 2 RIDGEDALE AVENUE STREET 2: SUITE 217 CITY: CEDAR KNOLLS STATE: NJ ZIP: 07927 BUSINESS PHONE: (973) 993-8001 MAIL ADDRESS: STREET 1: 2 RIDGEDALE AVENUE STREET 2: SUITE 217 CITY: CEDAR KNOLLS STATE: NJ ZIP: 07927 FORMER COMPANY: FORMER CONFORMED NAME: OMNIMED INTERNATIONAL, INC. DATE OF NAME CHANGE: 20051122 FORMER COMPANY: FORMER CONFORMED NAME: BIO SOLUTIONS INTERNATIONAL INC DATE OF NAME CHANGE: 20010214 FORMER COMPANY: FORMER CONFORMED NAME: SEPTIMA ENTERPRISES INC DATE OF NAME CHANGE: 19920703 8-K 1 form8k.htm MEDEFILE INTERNATIONAL, INC. FORM 8-K form8k.htm

 UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
____________________________________________________________
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
___________________________________________________________________
 
Date of Report (Date of earliest event reported):  August 15, 2011
 
Medefile International, Inc.
(Exact Name of Registrant as Specified in Charter)
 
Nevada
033-25126 D
85-0368333
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
 
 
301 Yamato Road
Suite 1200
Boca Raton, FL
33431
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code: (561) 912-3393
 
 
(Former name or former address, if changed since last report)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
The information in this Current Report on Form 8-K and the exhibits hereto is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
 

 
 
1

 
 
Item 2.02 Results of Operations and Financial Condition.

On August 15, 2011, Medefile International, Inc. (the “Company”) issued a press release announcing its financial results for the period ended June 30, 2011 and certain other information. A copy of the Company’s press release announcing these financial results and certain other information is attached hereto as Exhibit 99.1.
 
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by specific reference in such a filing.
 
Item 9.01

Exhibit No.
Description
99.1
Press Release dated August 15, 2011.
 

 
2

 
 


SIGNATURES

 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
MEDEFILE INTERNATIONAL, INC.
 
       
Date: August 19, 2011
By:
/s/ Kevin Hauser  
    Kevin Hauser  
    Chief Executive Officer  
       


 
 
 
 
3
EX-99.1 2 ex991.htm EXHIBIT 99.1 ex991.htm
Exhibit 99.1
 
 
MedeFile International Reports Second Quarter 2011 Results
 
Company Marks Fourth Consecutive Quarter of Double-Digit Revenue and Membership Growth
 
BOCA RATON, FL--(Marketwire -08/15/11)- MedeFile International, Inc. (OTCQB: MDFI.PK - News) (Pinksheets: MDFI.PK - News), a leader in Internet-enabled Personal Health Record (iPHR) management solutions, today announced its financial and operational results for the three and six months, ended June 30, 2011.
 
Financial Highlights for Three Months Ended June 30, 2011 Compared to Three Months Ended June 30, 2010:
 
  
Revenues rose to $187,740, representing a 43-fold (4325%) increase from $4,242.   
 
o  
When comparing subsequent quarter-over-quarter results, the Company posted its fourth consecutive quarter of double-digit growth, rising 42% from $132,102 reported for the three months ended March 31, 2011.   (See Chart)
 
  
Net loss declined 50% to $663,237, or $0.00 loss per basic and diluted share, from $1,326,658, or $0.00 loss per basic and diluted share.
 
Financial Highlights for Six Months Ended June 30, 2011 Compared to Six Months Ended June 30, 2010:
 
  
Revenues totaled $319,942, climbing significantly (4745%) from $6,602.   
 
  
Net loss was $1,111,429, or $0.00 loss per basic and diluted share, a 22% decrease from $1,417,198, or $0.00 loss per basic and diluted share.
 
As of June 30, 2011, cash totaled $311,975; there was zero long term debt; and stockholders' equity totaled $204,458.
 
Operational Highlights:
 
  
Total members registered on the MedeFile system was approximately 15,200 as of the end of June 30, 2011, up from approximately 7,000 as of March 31, 2011.   
 
  
Social marketing has helped spur a notable increase in people who are following MedeFile on Facebook, with the number of "likes" now totaling over 18,800, which is up nearly 11,000 just since May 2011.   
 
  
In an effort to support certain global growth opportunities presented to MedeFile by current strategic partners, the Company's web site and secure back-end member interface is now fully operational in English, Russian and Spanish.   MedeFile's web development team is currently focused on completing translations in German and French, both of which are expected to be completed in the third quarter.   
 
  
Last week, MedeFile announced that it will begin airing 60-second infomercials and four different six-minute interviews with the Company's Chairman, President and CEO Kevin Hauser, in an effort to promote mass market awareness of MedeFile and to educate U.S.   consumers on the need for and many benefits of MedeFile's personal health record solutions.   Over the year-long campaign produced by FMW Media Works (FMW), a minimum of 1,000 spots will be televised on ION and FOX cable networks and may be substituted at FMW's discretion on ABC, CBS, CNN and MSNBC in the following metro markets: New York, Los Angeles, Chicago, Dallas, Boston, Philadelphia, San Francisco/San Jose, Atlanta, Washington and Houston.   Although it is not possible to forecast with any level of accuracy the impact that this sponsored ad campaign will have on MedeFile's membership growth in the coming year, management is optimistic that this marketing strategy will -- at a minimum -- help to promote strong brand integrity and awareness among American consumers, investors and major stakeholders in the global healthcare industry.   
 
Commenting on other growth initiatives, Hauser noted that "In connection with numerous strategic collaborations formed with a broad range of entities over the past six months, we have continued to actively pursue discussions and negotiations with several potential new corporate, institutional and government clients to provide MedeFile Premium and MedeFile Lite subscriptions to their respective employees, customers and members via volume-driven wholesale contracts and upsell opportunities.   In this regard, it is anticipated that the Company will shortly be in a position to begin announcing key new contracts that hold the potential to be real 'game changers' for MedeFile -- significantly contributing to future recurring revenue, cash flow and earnings growth," stated Hauser.
 
"We couldn't be more excited about the direction MedeFile is heading and remain highly confident that strategies we are executing now will ultimately culminate in MedeFile winning worldwide recognition as the leading iPRH solutions provider," concluded Hauser.
 
 
 

 
 
 
FINANCIAL CHARTS FOLLOW
 
MEDEFILE INTERNATIONAL, INC.
BALANCE SHEETS
 
             
   
Unaudited
       
   
June 30,
   
December 31,
 
Assets
 
2011
   
2010
 
Current assets
           
Cash
  $ 311,975     $ 499,652  
Inventory
    27,904       22,184  
Merchant services reserve
    53,267       6,173  
Accounts receivable, net
    2,810       2,468  
Prepaid Insurance
    4,494       -  
Total current assets
    400,450       530,477  
Website development, net of accumulated amortization
    36,718       47,210  
Furniture and equipment, net of accumulated depreciation
    15,251       20,364  
Investment
    1,800       -  
Intangibles
    1,339       1,339  
Total assets
  $ 455,558     $ 599,390  
                 
Liabilities and Stockholders' Equity
               
Accounts payable and accrued liabilities
  $ 244,379     $ 310,325  
Cash overdraft
    -       6,928  
Deferred revenues
    6,721       9,575  
Total Current Liabilities
    251,100       326,828  
                 
                 
Stockholders' Equity
               
Preferred stock, $.0001 par value: 10,000 authorized,
               
no shares issued and outstanding
    -       -  
Common stock, $.0001 par value: 5,000,000,000 authorized;
               
3,678,049,471 and 3,450,021,410 shares issued and outstanding on
               
June 30, 2011 and December 31, 2010, respectively
    367,805       345,002  
Common stock payable
    159,000       -  
Additional paid in capital
    16,951,638       16,090,116  
Accumulated deficit
    (17,273,985 )     (16,162,556 )
Total stockholders' equity
    204,458       272,562  
Total liability and stockholders' equity
  $ 455,558     $ 599,390  
 

 
4

 
 

MEDEFILE INTERNATIONAL, INC.
STATEMENT OF OPERATIONS
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2011 AND JUNE 30, 2010
 
                         
   
For the Three
   
For the Three
   
For the Six
   
For the Six
 
   
Months
   
Months
   
Months
   
Months
 
   
Ended
   
Ended
   
Ended
   
Ended
 
   
June 30,
   
June 30,
   
June 30,
   
June 30,
 
   
2011
   
2010
   
2011
   
2010
 
Revenue
  $ 187,740     $ 4,242     $ 319,842     $ 6,602  
                                 
Cost of goods sold
    90,267       -       153,741       -  
Gross profit
    97,473       4,242       166,101       6,602  
                                 
Operating expenses
                               
Selling, general and administrative expenses
    442,085       101,135       821,205       180,309  
Maketing expense
    310,867       -       440,721       -  
Depreciation and amortization expense
    7,758       9,441       15,604       13,692  
Total operating expenses
    760,710       110,576       1,277,530       194,001  
                                 
Loss from operations
    (663,237 )     (106,334 )     (1,111,429 )     (187,399 )
                                 
Other expenses
                               
Interest expense  - note payable
    -       (3,879 )     -       (10,166 )
Interest expense - related party note payable
    -       (1,216,445 )     -       (1,219,633 )
Total other expenses
    -       (1,220,324 )     -       (1,229,799 )
                                 
Loss before income tax
    (663,237 )     (1,326,658 )     (1,111,429 )     (1,417,198 )
Provision for income tax
    -       -       -       -  
Net Loss
  $ (663,237 )   $ (1,326,658 )   $ (1,111,429 )   $ (1,417,198 )
                                 
Net loss per share: basic and diluted
  $ (0.00 )   $ (0.00 )   $ (0.00 )   $ (0.00 )
                                 
Weighted average share outstanding
    3,584,124,074       1,463,021,410       3,517,124,825       1,463,021,410  
basic and diluted
                               
 
 
5

 
 
About MedeFile International, Inc.   
 
Headquartered in South Florida, MedeFile has developed and globally markets a proprietary, patient-centric, iPHR (Internet-enabled Personal Health Record) system for gathering, digitizing and organizing medical records so that individuals can have a comprehensive record of all of their medical visits.   MedeFile's primary product is its web-based MedeFile solution, a highly secure system for gathering, maintaining, accessing and sharing personal medical records.   Interoperable with most electronic medical record management systems marketed to the healthcare industry, the MedeFile solution is designed to gather all of its members' actual medical records and create a single, comprehensive Electronic Health Record (EHR) that is accessible 24 hours a day, seven days a week by the member and the member's authorized users on any web-enabled device (PC, cell phone, smartphone, e-reader) and portable MedeDrive unit.   For more information about MedeFile and its annual subscription-based programs, please visit www.medefile.com.   You can also follow the Company on Facebook!
 
Safe Harbor Statement Under the Private Securities Litigation Act of 1995
 
With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties.   The actual future results of MedeFile could differ significantly from those statements.   Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities.   In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology.   These statements are only predictions.   Although we believe that the expectations reflected in the forward-looking statements are reasonable, and such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved.   We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise.   In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements.   For further risk factors associated with our Company, review our SEC filings.